Search research articles
Contact Us
Filters
Showing results (51-60 of 209) with videos related to
Page
of 21
Sort By:
American Journal of Clinical Dermatology
|
January 1, 2016
US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey
Mark G Lebwohl, Arthur Kavanaugh, April W Armstrong, et al.
Archives of Dermatology
|
January 21, 2003
Ultraviolet radiation in alpine skiing: magnitude of exposure and importance of regular protection
Ethan G Rigel, Mark G Lebwohl, Adam C Rigel, et al.
Journal of Drugs in Dermatology : JDD
|
October 3, 2013
Combination use of ustekinumab with other systemic therapies: a retrospective study in a tertiary referral center
Gillian M Heinecke, Adam J Luber, Jacob O Levitt, et al.
Journal of Drugs in Dermatology : JDD
|
January 11, 2024
Post-Hyaluronic Acid Filler Reaction Treated With Abrocitinib: A Case Report
Miyahra Haniko P Lopez, Sophie H Guenin, Jennifer Laborada, et al.
International Journal of Dermatology
|
August 12, 2004
Use of Ber-EP4 protein in recurrent metastatic basal cell carcinoma: a case report and review of the literature
Rao N Saladi, Fiza Singh, Huachen Wei, et al.
JAMA Dermatology
|
August 16, 2013
Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011
April W Armstrong, Andrew D Robertson, Julie Wu, et al.
Journal of Drugs in Dermatology : JDD
|
June 20, 2017
Assessment of Efficacy and Irritation of Ingenol Mebutate Gel 0.015% Used With or Without Dimethicone Lotion for Treatment of Actinic Keratosis on the Face
Shelbi C Jim On, Peter W Hashim, John K Nia, et al.
Journal of Drugs in Dermatology : JDD
|
October 5, 2019
Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials
Mark G. Lebwohl, Jeffrey L. Sugarman, Linda Stein Gold, et al.
Dermatology and Therapy
|
August 25, 2022
Clinical Efficacy and Safety of Psoriasis Treatments in Patients with Concomitant Metabolic Syndrome: A Narrative Review
Joseph F Merola, Arthur Kavanaugh, Mark G Lebwohl, et al.
Journal of the American Academy of Dermatology
|
November 14, 2013
From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti-tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis
Kiran Motaparthi, Vladimir Stanisic, Abby S Van Voorhees, et al.
Page
of 21
Search research articles
Search
Showing results (51-60 of 209) with videos related to
Sort By:
Page
of 21
American Journal of Clinical Dermatology
|
January 1, 2016
US Perspectives in the Management of Psoriasis and Psoriatic Arthritis: Patient and Physician Results from the Population-Based Multinational Assessment of Psoriasis and Psoriatic Arthritis (MAPP) Survey
Mark G Lebwohl, Arthur Kavanaugh, April W Armstrong, et al.
Archives of Dermatology
|
January 21, 2003
Ultraviolet radiation in alpine skiing: magnitude of exposure and importance of regular protection
Ethan G Rigel, Mark G Lebwohl, Adam C Rigel, et al.
Journal of Drugs in Dermatology : JDD
|
October 3, 2013
Combination use of ustekinumab with other systemic therapies: a retrospective study in a tertiary referral center
Gillian M Heinecke, Adam J Luber, Jacob O Levitt, et al.
Journal of Drugs in Dermatology : JDD
|
January 11, 2024
Post-Hyaluronic Acid Filler Reaction Treated With Abrocitinib: A Case Report
Miyahra Haniko P Lopez, Sophie H Guenin, Jennifer Laborada, et al.
International Journal of Dermatology
|
August 12, 2004
Use of Ber-EP4 protein in recurrent metastatic basal cell carcinoma: a case report and review of the literature
Rao N Saladi, Fiza Singh, Huachen Wei, et al.
JAMA Dermatology
|
August 16, 2013
Undertreatment, treatment trends, and treatment dissatisfaction among patients with psoriasis and psoriatic arthritis in the United States: findings from the National Psoriasis Foundation surveys, 2003-2011
April W Armstrong, Andrew D Robertson, Julie Wu, et al.
Journal of Drugs in Dermatology : JDD
|
June 20, 2017
Assessment of Efficacy and Irritation of Ingenol Mebutate Gel 0.015% Used With or Without Dimethicone Lotion for Treatment of Actinic Keratosis on the Face
Shelbi C Jim On, Peter W Hashim, John K Nia, et al.
Journal of Drugs in Dermatology : JDD
|
October 5, 2019
Efficacy, Safety, and Tolerability of a Halobetasol 0.01% /Tazarotene 0.045% Fixed Combination in the Treatment of Severe Localized Plaque Psoriasis: Post Hoc Analysis of Two Phase III Randomized Controlled Trials
Mark G. Lebwohl, Jeffrey L. Sugarman, Linda Stein Gold, et al.
Dermatology and Therapy
|
August 25, 2022
Clinical Efficacy and Safety of Psoriasis Treatments in Patients with Concomitant Metabolic Syndrome: A Narrative Review
Joseph F Merola, Arthur Kavanaugh, Mark G Lebwohl, et al.
Journal of the American Academy of Dermatology
|
November 14, 2013
From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti-tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis
Kiran Motaparthi, Vladimir Stanisic, Abby S Van Voorhees, et al.
Page
of 21